| 11597746 |
Cyclic dinucleotides as sting agonists |
Mark Richter, Peter J. Connolly, James P. Edwards, Guangyi Wang, Santhosh Kumar Thatikonda +5 more |
2023-03-07 |
$225,152,000 |
| 11492367 |
Cyclic dinucleotides as sting agonists |
Mark Richter, Peter J. Connolly, James P. Edwards, Guangyi Wang, Santhosh Kumar Thatikonda +6 more |
2022-11-08 |
$222,911,000 |
| 11472830 |
Cyclic dinucleotides as sting agonists |
Gilles Bignan, Peter J. Connolly, James P. Edwards, Sylvie Laquerre, Tianbao Lu +5 more |
2022-10-18 |
$502,333,000 |
| 11021511 |
Cyclic dinucleotides as sting agonists |
Mark Richter, Peter J. Connolly, James P. Edwards, Guangyi Wang, Santhosh Kumar Thatikonda +3 more |
2021-06-01 |
$144,078,000 |
| 10954286 |
Bispecific EGFR/IGFIR binding molecules |
Linda Engle, Ray Camphausen, Martin C. Wright, Ginger Rakestraw, Marco Gottardis +1 more |
2021-03-23 |
|
| 10781247 |
Targeted therapeutics based on engineered proteins that bind EGFR |
Ray Camphausen, Brent Morse, David Fabrizio |
2020-09-22 |
|
| 10183987 |
Polynucleotides encoding bispecific EGFR/IGF-IR binding molecules |
Linda Engle, Ray Camphausen, Martin C. Wright, Ginger Rakestraw, Marco Gottardis +1 more |
2019-01-22 |
|
| 9920108 |
Targeted therapeutics based on engineered proteins that bind EGFR |
Ray Camphausen, Brent Morse, David Fabrizio |
2018-03-20 |
|
| 9771411 |
Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules |
Linda Engle, Ray Camphausen, Martin C. Wright, Ginger Rakestraw, Marco Gottardis +1 more |
2017-09-26 |
|
| 9234028 |
Targeted therapeutics based on engineered proteins that bind EGFR |
Ray Camphausen, Brent Morse, David Fabrizio |
2016-01-12 |
|
| 9017655 |
Bispecific EGFR/IGFIR binding molecules |
Linda Engle, Ray Camphausen, Martin C. Wright, Ginger Rakestraw, Marco Gottardis +1 more |
2015-04-28 |
$246,231,000 |
| 8524244 |
Targeted therapeutics based on engineered proteins that bind EGFR |
Ray Camphausen, Brent Morse, David Fabrizio |
2013-09-03 |
$269,034,000 |
| 8367825 |
Substituted pyrimidinyl oxime kinase inhibitors |
Xu Guozhang, Lily Lee, Terry Vincent Hughes, Steven K. Wetter, Peter J. Connolly +5 more |
2013-02-05 |
$58,419,000 |
| 8343501 |
Bispecific EGFR/IGFIR binding molecules |
Linda Engle, Ray Camphausen, Martin C. Wright, Ginger Chao, Marco Gottardis +1 more |
2013-01-01 |
|
| 8314234 |
Bicyclic pyrimidine kinase inhibitors |
Peter J. Connolly, Ronghui Lin, Yanhua Lu, Steven A. Middleton |
2012-11-20 |
$86,339,000 |
| 8299082 |
1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
Shenlin Huang, Ronghui Lin, Peter J. Connolly, Steven A. Middleton, Robert H. Gruninger +1 more |
2012-10-30 |
|
| 8153791 |
Substituted pyrimidinyl oxime kinase inhibitors |
Guozhang Xu, Lily Lee, Terry Vincent Hughes, Steven K. Wetter, Peter J. Connolly +5 more |
2012-04-10 |
$74,571,000 |
| 7888380 |
1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives |
Shenlin Huang, Ronghui Lin, Peter J. Connolly, Steven A. Middleton, Robert H. Gruninger +1 more |
2011-02-15 |
$77,713,000 |
| 7855205 |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders |
Shenlin Huang, Ronghua Li, Peter J. Connolly, Steven A. Middleton |
2010-12-21 |
$90,381,000 |
| 7795440 |
N-substituted tricyclic 1-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders |
Chih Yung Ho, Bengt Anders Brunmark, Robert A. Galemmo, Jr., Dana L. Johnson, Donald Ludovici +6 more |
2010-09-14 |
$62,961,000 |
| 7541367 |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
George Chiu, Peter J. Connolly, Shenlin Huang, Shengjian Li, Ronghui Lin +2 more |
2009-06-02 |
$278,771,000 |
| 7427625 |
Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors |
Peter J. Connolly, Stuart Hayden, Sigmond Johnson, Bharat Lagu, Steven A. Middleton +2 more |
2008-09-23 |
$476,683,000 |
| 7317031 |
Substituted triazole diamine derivatives as kinase inhibitors |
Ronghui Lin, Shenlin Huang, Steven K. Wetter, Peter J. Connolly, Robert H. Gruninger +1 more |
2008-01-08 |
$17,632,000 |
| 7205298 |
Substituted triazine kinase inhibitors |
Gee-Hong Kuo, Alan R. DeAngelis, Aihua Wang, Yan Zhang, Steve Middleton |
2007-04-17 |
$101,901,000 |
| 7196110 |
N-substituted tricyclic 3-aminopyrazoles as inhibitors for the treatment of cell proliferative disorders |
Chih Yung Ho, Bengt Anders Brunmark, Robert A. Galemmo, Jr., Dana L. Johnson, Donald Ludovici +6 more |
2007-03-27 |
$178,653,000 |
